Breast Cancer News

A five-factor risk model effectively predicted 2-year lymphedema-free survival among a cohort of patients with breast cancer, according to findings published in JAMA Network Open.

The FDA has approved two new biosimilars of denosumab to treat osteoporosis, increase bone mass, prevent skeletal-related events for people with multiple myeloma and other indications, Samsung Bioepis announced.

Use of a home-based electronic monitoring system for symptom reporting reduced ED visits among people receiving treatment for metastatic cancer, according to study findings.

Genomic cancer predisposition tests should be done with professional counseling, and the FDA should implement safeguards for direct-to-consumer products, according to a medical oncologist with expertise in cancer genetics.

In this video, Aruna Padmanabhan, MD, encourages new residents to explore the outpatient treatment landscape and physician collaboration in the field of metastatic breast cancer.

In this video, Aruna Padmanabhan, MD, discusses the effectiveness of cyclin-dependent kinase inhibitors in the treatment of metastatic hormone-positive breast cancer.

In this video, Aruna Padmanabhan, MD, discusses the management of side effects seen in patients receiving PI3K inhibitors for the treatment of PIK3CA-mutated breast cancer.

In this video, Aruna Padmanabhan, MD, discusses the evaluation of PI3K inhibitor combinations as first-line treatment for patients with metastatic breast cancer.

In this video, Aruna Padmanabhan, MD, discusses therapy combinations for the treatment of PIK3CA-mutated metastatic breast cancer.